| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. | N Engl J Med | 2010 | 36.78 |
| 2 | Crizotinib in ROS1-rearranged non-small-cell lung cancer. | N Engl J Med | 2014 | 6.95 |
| 3 | Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. | J Clin Oncol | 2012 | 1.48 |
| 4 | Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. | Mol Cancer Res | 2009 | 1.36 |
| 5 | The role of metastasis suppressor genes in metastatic dormancy. | APMIS | 2008 | 1.21 |